Phospho-HAND1 (S98) Antibody

What is HAND1 and why is phosphorylation at S98 significant?

HAND1 (Heart and neural crest derivatives expressed protein 1) is a basic helix-loop-helix (bHLH) transcription factor that plays crucial roles in developmental processes. Also known as eHAND, Thing1, or bHLHa27, this protein is approximately 22 kDa and functions in embryonic development, particularly in cardiac, limb, and neural crest formation .

Phosphorylation at serine 98 (S98) represents a key post-translational modification that regulates HAND1's functionality. Research has demonstrated that:

• S98 phosphorylation affects HAND1's ability to form dimers with other bHLH transcription factors

• This modification influences transcriptional regulation of downstream target genes

• Phosphorylation status at S98 appears to be developmentally regulated

The importance of S98 phosphorylation was identified through phosphopeptide mapping studies, which revealed that this site is specifically targeted by certain kinases during trophoblast giant cell differentiation .

What experimental applications are supported by Phospho-HAND1 (S98) antibodies?

Phospho-HAND1 (S98) antibodies support multiple experimental applications in developmental biology and molecular research. Based on manufacturer specifications and published research applications, these antibodies can be utilized in:

These antibodies are particularly valuable for tracking developmental changes in HAND1 phosphorylation status in neural crest cells, limb mesenchyme, and cardiac tissues. Researchers have successfully used these antibodies to demonstrate altered phosphorylation patterns during cell differentiation and in response to signaling pathway activation .

How should researchers validate the specificity of Phospho-HAND1 (S98) antibodies?

Validating antibody specificity is critical for reliable experimental outcomes. For Phospho-HAND1 (S98) antibodies, multiple validation approaches should be employed:

Recommended validation strategy:

• Phosphatase treatment control: Compare antibody reactivity in samples with and without lambda phosphatase (λPP) treatment. Loss of signal after phosphatase treatment confirms phospho-specificity .

• Mutation analysis: Generate S98A (non-phosphorylatable) HAND1 mutants and demonstrate loss of antibody reactivity .

• Peptide competition assay: Pre-incubate antibody with phosphorylated and non-phosphorylated peptides containing the S98 epitope. Specific signal should be blocked only by the phosphorylated peptide .

• Flow cytometry-based specificity quantification: Implement the Φ (phi) value determination using transfected versus non-transfected cells, where Φ values near 1 indicate high specificity. This approach is particularly valuable for phospho-specific antibodies .

• Cross-reactivity assessment: Test antibody against other phosphorylated proteins with similar epitopes to rule out non-specific binding .

Some commercial Phospho-HAND1 (S98) antibodies have been specifically purified to remove non-phospho-specific antibodies through chromatography using non-phosphopeptide , which enhances their specificity.

What are the optimal storage and handling conditions for Phospho-HAND1 (S98) antibodies?

Proper storage and handling are essential for maintaining antibody functionality and experimental reproducibility. For Phospho-HAND1 (S98) antibodies:

Storage recommendations:

• Store at -20°C for long-term preservation

• Consider aliquoting to minimize freeze-thaw cycles

• For frequently used antibodies, some manufacturers permit storage at 4°C for up to one month

Buffer composition:
Most commercial preparations are supplied in PBS containing:

• 50% glycerol (cryoprotectant)

• 0.5% BSA (stabilizer)

• 0.02% sodium azide (preservative)

Working dilution preparation:

• Dilute in appropriate buffer immediately before use

• For immunohistochemistry applications: 1:100-1:300 dilution in blocking buffer

• For ELISA: 1:10000 dilution in assay buffer

• For Western blotting: 1:1000 dilution in blocking buffer

Handling precautions:

• Avoid repeated freeze-thaw cycles

• Centrifuge briefly before opening vials

• Use sterile techniques to prevent contamination

• Note that sodium azide is toxic and incompatible with certain applications (e.g., HRP-based detection systems)

How does phosphorylation at S98 affect HAND1's dimerization behavior compared to other phosphorylation sites?

HAND1's function as a transcription factor depends critically on its dimerization with other bHLH proteins. Phosphorylation at S98 significantly impacts this dimerization profile, although differently than other phosphorylation sites:

S98 phosphorylation effects:

• Promotes selective dimerization with certain bHLH partners

• Affects DNA-binding affinity to target sequences

• Influences transcriptional activation potential

Comparative analysis with other phosphorylation sites:
Research has demonstrated that T107 and S109 phosphorylation sites in HAND1 also affect dimerization but through distinct mechanisms:

Importantly, phosphopeptide mapping experiments have revealed that "phosphorylation of T107 is required for phosphorylation of S109," suggesting a hierarchical relationship between these modifications . Mutational studies have shown that altering HAND1 phosphoregulation through T107A and S109A mutations disrupts normal developmental processes in a non-cell-autonomous manner, affecting signaling pathways including Fgf8 and Shh .

Advanced phosphopeptide mapping with mutational analysis demonstrated that "When expressed within the neural crest, Hand1 phospho-mutants caused non-cell-autonomous cell death within the forming mandibular arch, altering gene expression within both the Fgf and Shh signaling pathways" , highlighting the profound downstream effects of altered HAND1 phosphorylation.

What methodologies are most effective for studying HAND1 S98 phosphorylation dynamics in developmental contexts?

Investigating the temporal and spatial dynamics of HAND1 S98 phosphorylation during development requires specialized methodologies:

Recommended methodological approach:

• Metabolic labeling with 32P:

  • Co-express Flag-tagged HAND1 with active kinases or phosphatase subunits in tissue culture cells

  • Perform metabolic labeling with 32P

  • Immunoprecipitate HAND1 and generate phosphopeptide maps

• Phospho-specific antibody time-course analysis:

  • Utilize Phospho-HAND1 (S98) antibodies in Western blot time-course studies

  • Compare with total HAND1 expression to determine phosphorylation ratios

  • Integrate with developmental stage markers

• Conditional expression of phospho-mutants:

  • Generate conditional knock-in alleles with tissue-specific Cre expression

  • Create S98A (phospho-null) and S98D (phospho-mimetic) HAND1 variants

  • Analyze phenotypic consequences in relevant developmental contexts

• Single-cell resolution phosphoprotein detection:

  • Implement integrated single-cell (phospho-)protein and RNA detection

  • This approach allows unbiased detection of phosphorylation events across heterogeneous cell populations

Studies using these approaches have revealed that altering HAND1 phosphoregulation in neural crest cells results in "severe mid-facial clefting and neonatal death" with "abnormal cell death within the developing PAs, resulting in reduced outgrowth of the maxillary processes and aberrant craniofacial development" , demonstrating the power of these methodologies.

What are the upstream kinases and signaling pathways regulating HAND1 S98 phosphorylation?

Understanding the regulation of HAND1 phosphorylation requires knowledge of the upstream kinases and signaling cascades. Research has identified several key regulators:

Kinases implicated in HAND1 S98 phosphorylation:

Signaling pathway integration:
HAND1 S98 phosphorylation status is affected by several developmental signaling pathways:

• FGF signaling: Altered HAND1 phosphorylation affects Fgf8 expression, suggesting a potential feedback loop

• Hedgehog pathway: Modified HAND1 phosphorylation results in changes to Shh, Ptch1, and Gli1 expression

• Neural crest specification pathways: Phospho-regulation of HAND1 influences neural crest cell survival and patterning

How can researchers design experiments to investigate the transcriptional consequences of altered HAND1 S98 phosphorylation?

Investigating how S98 phosphorylation affects HAND1's transcriptional activity requires sophisticated experimental designs:

Recommended experimental approach:

• Conditional expression systems:

  • Generate cell lines or animal models with inducible expression of wild-type HAND1, S98A (phospho-null), or S98D (phospho-mimetic) variants

  • Utilize tissue-specific promoters (e.g., Wnt1-Cre for neural crest, Prrx1-Cre for limb mesenchyme)

• Chromatin immunoprecipitation (ChIP) analysis:

  • Compare genomic binding profiles of wild-type versus phospho-mutant HAND1

  • Identify differentially bound genomic regions

  • Integrate with transcriptomic data to correlate binding with gene expression changes

• Target gene expression analysis:

  • Perform qRT-PCR on key developmental genes after modulating HAND1 phosphorylation

  • Focus on pathways known to be affected (Fgf8, Shh, Gli1, Ptch1)

  • Example finding: "both Shh and Gli1 expression are significantly enhanced in both Hand1 phospho-mutants"

• Dimerization partner profiling:

  • Use co-immunoprecipitation to identify how S98 phosphorylation affects HAND1's interaction partners

  • Compare wild-type versus phospho-mutant HAND1 interactomes

  • This approach can reveal shifts in dimerization preference that impact transcriptional targets

• Phenotypic rescue experiments:

  • Test whether the phenotypes caused by phospho-mutant HAND1 can be rescued by modulating expression of downstream genes

  • For example, research showed that "removing the wild-type Hand1 allele on both the Hand1 PO4− and Hand1 PO4+ backgrounds results in reduced levels of cell death and improved craniofacial development"

These approaches have revealed that altered HAND1 phosphorylation produces non-cell-autonomous effects, suggesting that "Hand1 and its putative bHLH dimer partners transcriptionally control one or more of the theorized cap signals central to the 'Hinge and Caps' model of PA patterning" .

What are the technical considerations for phosphopeptide mapping of HAND1 S98 phosphorylation?

Phosphopeptide mapping is a powerful technique for analyzing HAND1 phosphorylation sites, but requires careful technical considerations:

Detailed phosphopeptide mapping protocol:

These technical considerations are essential for accurate interpretation of HAND1 phosphorylation patterns and their functional significance.

How do HAND1 S98 phosphorylation effects differ between neural crest and limb development contexts?

HAND1 phosphorylation produces context-specific effects in different developmental tissues:

Neural crest development effects:

Limb development effects:

Comparative analysis:

These context-specific effects highlight the importance of tissue-specific analysis when studying HAND1 phosphorylation and suggest that "the Twist-family bHLH dimer pool" has differential composition and function in these distinct developmental contexts.